Natures Willow Bug Bite Patch
Calendula, Salix Alba
Wb Ventures Llc
Human Otc Drug
NDC 73498-025Natures Willow Bug Bite Patch also known as Calendula, Salix Alba is a human otc drug labeled by 'Wb Ventures Llc'. National Drug Code (NDC) number for Natures Willow Bug Bite Patch is 73498-025. This drug is available in dosage form of Patch. The names of the active, medicinal ingredients in Natures Willow Bug Bite Patch drug includes Calendula Officinalis Flower - .002 mg/1 Salix Alba Bark - .004 mg/1 . The currest status of Natures Willow Bug Bite Patch drug is Active.
Drug Information:
| Drug NDC: | 73498-025 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Natures Willow Bug Bite Patch |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Calendula, Salix Alba |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Wb Ventures Llc |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Patch |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | CALENDULA OFFICINALIS FLOWER - .002 mg/1
SALIX ALBA BARK - .004 mg/1
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 08 Dec, 2021 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 14 Jun, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | WB Ventures LLC
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 0860005199822
|
| UPC stands for Universal Product Code. |
| UNII: | P0M7O4Y7YD
205MXS71H7
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 73498-025-01 | 4 POUCH in 1 BOX (73498-025-01) / 10 PATCH in 1 POUCH | 08 Dec, 2021 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose purpose* calendula officinalis flower extract 0.002 mg reduces scarring, speeds healing salix alba (willow) bark extract 0.004 mg topical analgesic
Product Elements:
Natures willow bug bite patch calendula, salix alba zanthoxylum bungeanum fruit linolenic acid oleyl alcohol eucalyptus oil lavender oil linalool, (+/-)- helichrysum italicum flower oil peppermint oil menthol geranium oil, algerian type propylene glycol calendula officinalis flower calendula officinalis flower salix alba bark salix alba bark grape seed oil butyl acrylate/methyl methacrylate/methacrylic acid copolymer (18000 mw) soybean oil alpha-tocopherol acetate limonene, (+/-)-
Indications and Usage:
Uses uses* for the temporary relief of symptoms associated with insect bites.
Warnings:
Warnings for external use only. avoid contact with eyes, mucous membranes, damaged skin or wounds. do not use if you are allergic to any ingredients in this product or by persons with known sensitivity to aspirin. stop use and ask a doctor if symptoms worsen or persist for more than 7 days. if pregnant or breast-feeding , ask a healthcare professional before use. discontinue treatment in case of skin irritation, redness or rash occurs.
Dosage and Administration:
Directions adults and children over 12 years of age: 1. clean and dry the affected area. 2. peel off a patch from the transparent backing. 3. apply carefully on the affeced area. to prevent touching the patch with your fingers, use the side tab. 4. keep the patch on until the nuisance is gone. do not exceed 8 hours of application. children under 12 years of age: consult a physician
Package Label Principal Display Panel:
Package label box label
Further Questions:
Questions or comments? questions or comments? 1-888-609-4556